Pain assessment using physiological responses/markers in different types of pain: a scoping review - Top-Institutions - MDSpire

Pain assessment using physiological responses/markers in different types of pain: a scoping review

  • By

  • Camila Camacho-Navas

  • Ling Li

  • Kavita Poply

  • Vivek Mehta

  • Panicos Kyriacou

  • January 15, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Pain Medicine
    • Neuroscience
    • Biomedical Engineering

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Pain Medicine
    • Neurology
    • Clinical Research

  • #3

    Massachusetts General Hospital / Harvard Medical School
    Massachusetts General Hospital / Harvard Medical School

    Boston, MA

    Key Differentiators

    • Pain Medicine
    • Neuroscience
    • Biomedical Informatics

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Pain Medicine
    • Neuroscience
    • Biomedical Engineering

  • #5

    University of Pittsburgh
    University of Pittsburgh

    Pittsburgh, PA

    Key Differentiators

    • Pain Medicine
    • Neuroscience
    • Biomedical Informatics

Original Source(s)

Pain assessment using physiological responses/markers in different types of pain: a scoping review

  • by Camila Camacho-Navas, Ling Li, Kavita Poply, Vivek Mehta, Panicos Kyriacou

  • January 15, 2026

Related Content

Venetoclax combined with azacitidine in the treatment of secondary myelodysplastic syndrome following multiple myeloma: a case report and literature review

A staged adoption pathway for intraoperative imaging in brain tumor surgery: cost-effectiveness and accessibility in resource-limited neurosurgical settings

Papulopustular eruptions associated with EGFR-pathway-related targeted therapies: clinical spectrum, evidence boundaries, folliculocentric inflammation, and management considerations